{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:59:07Z","timestamp":1791950347544,"version":"4.3.4"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2013,8,19]],"date-time":"2013-08-19T00:00:00Z","timestamp":1376870400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0072185","type":"journal-article","created":{"date-parts":[[2013,8,19]],"date-time":"2013-08-19T20:58:36Z","timestamp":1376945916000},"page":"e72185","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Comparing Adjuvanted H28 and Modified Vaccinia Virus Ankara Expressing H28 in a Mouse and a Non-Human Primate Tuberculosis Model"],"prefix":"10.1371","volume":"8","author":[{"given":"Rolf","family":"Billeskov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan P.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Aagaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,8,19]]},"reference":[{"key":"ref1","unstructured":"Anon (2011) Global tuberculosis control: WHO report 2011. Geneva, Switzerland: World Health Organization."},{"key":"ref2","first-page":"401","article-title":"Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection. J. Infect. Dis","volume":"185","author":"T Lillebaek","year":"2002"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"PE Fine","year":"1995","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature","volume":"96","author":"GA Colditz","year":"1995","journal-title":"Pediatrics"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature [see comments]","volume":"271","author":"GA Colditz","year":"1994","journal-title":"JAMA"},{"key":"ref6","first-page":"1973","article-title":"Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J. Exp. Med","volume":"189","author":"SM Behar","year":"1999"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"12013","DOI":"10.1073\/pnas.89.24.12013","article-title":"Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection","volume":"89","author":"JL Flynn","year":"1992","journal-title":"ProcNatlAcadSciUSA"},{"key":"ref8","first-page":"e1000392","article-title":"A critical role for CD8 T cells in a nonhuman primate model of tuberculosis. PLoS Pathog","volume":"5","author":"CY Chen","year":"2009"},{"key":"ref9","first-page":"390","article-title":"T-cell-mediated protection of mice against virulent Mycobacterium tuberculosis. Infect. Immun","volume":"57","author":"C Leveton","year":"1989"},{"key":"ref10","first-page":"2282","article-title":"Inflammatory response following intranasal infection with Mycobacterium avium complex: role of T-cell subsets and gamma interferon. Infect. Immun","volume":"63","author":"BM Saunders","year":"1995"},{"key":"ref11","first-page":"2243","article-title":"Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med","volume":"178","author":"AM Cooper","year":"1993"},{"key":"ref12","first-page":"2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med","volume":"178","author":"JL Flynn","year":"1993"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1359-6101(00)00010-1","article-title":"Interferon-gamma and interleukin-12 pathway defects and human disease","volume":"11","author":"SE Dorman","year":"2000","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e9611","DOI":"10.1371\/journal.pone.0009611","article-title":"Reactivation of latent tuberculosis in cynomolgus macaques infected with SIV is associated with early peripheral T cell depletion and not virus load","volume":"5","author":"CR Diedrich","year":"2010","journal-title":"PLoS One"},{"key":"ref15","first-page":"S178","article-title":"Update on research and development pipeline: tuberculosis vaccines. Clin. Infect. Dis","volume":"50","author":"B Beresford","year":"2010"},{"key":"ref16","first-page":"1539","article-title":"Tuberculosis subunit vaccines: from basic science to clinical testing. Expert. Opin. Biol. Ther","volume":"7","author":"TM Doherty","year":"2007"},{"key":"ref17","first-page":"8047","article-title":"Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells. J. Immunol","volume":"182","author":"T Lindenstrom","year":"2009"},{"key":"ref18","first-page":"843","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med","volume":"13","author":"PA Darrah","year":"2007"},{"key":"ref19","first-page":"4955","article-title":"Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice. J. Immunol","volume":"181","author":"EK Forbes","year":"2008"},{"key":"ref20","first-page":"2222","article-title":"Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load. J. Immunol","volume":"187","author":"CL Day","year":"2011"},{"key":"ref21","first-page":"2211","article-title":"Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection. Eur. J. Immunol","volume":"40","author":"N Caccamo","year":"2010"},{"key":"ref22","first-page":"723","article-title":"Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur. J. Immunol","volume":"39","author":"JS Sutherland","year":"2009"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e5264","DOI":"10.1371\/journal.pone.0005264","article-title":"MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques","volume":"4","author":"FA Verreck","year":"2009","journal-title":"PLoS One"},{"key":"ref24","first-page":"3364","article-title":"Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis. Infect. Immun","volume":"77","author":"HM Vordermeier","year":"2009"},{"key":"ref25","first-page":"1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara. J. Immunol","volume":"171","author":"NP Goonetilleke","year":"2003"},{"key":"ref26","first-page":"522","article-title":"Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study design. Lancet. Infect. Dis","volume":"6","author":"HB Ibanga","year":"2006"},{"key":"ref27","first-page":"1240","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat. Med","volume":"10","author":"H McShane","year":"2004"},{"key":"ref28","first-page":"544","article-title":"Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa. J. Infect. Dis","volume":"198","author":"T Hawkridge","year":"2008"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"MD Tameris","year":"2013","journal-title":"Lancet"},{"key":"ref30","first-page":"622","article-title":"Immunogenicity and protective efficacy of prime-boost regimens with recombinant (delta)ureC hly+ Mycobacterium bovis BCG and modified vaccinia virus ankara expressing M. tuberculosis antigen 85A against murine tuberculosis. Infect. Immun","volume":"77","author":"EZ Tchilian","year":"2009"},{"key":"ref31","first-page":"1170","article-title":"Establishment of an aerosol challenge model of tuberculosis in rhesus macaques, and an evaluation of endpoints for vaccine testing. Clin. Vaccine. Immunol","volume":"8","author":"SA Sharpe","year":"2010"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1016\/j.vaccine.2010.02.094","article-title":"Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naive human volunteers","volume":"28","author":"JT van Dissel","year":"2010","journal-title":"Vaccine"},{"key":"ref33","first-page":"279","article-title":"TB vaccines: current status and future perspectives. Immunol. Cell. Biol","volume":"87","author":"C Aagaard","year":"2009"},{"key":"ref34","first-page":"6332","article-title":"Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy. J. Immunol","volume":"174","author":"J Dietrich","year":"2005"},{"key":"ref35","first-page":"717","article-title":"Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol","volume":"43","author":"JC Betts","year":"2002"},{"key":"ref36","first-page":"189","article-title":"A multistage tuberculosis vaccine that confers efficient protection pre\u2013 and post\u2013exposure. Nature Medicine","volume":"2","author":"C Aagaard","year":"2011"},{"key":"ref37","first-page":"303","article-title":"The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection. J. Clin. Invest","volume":"122","author":"PL Lin","year":"2012"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"7442","DOI":"10.1016\/j.vaccine.2009.05.095","article-title":"Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strain","volume":"27","author":"M Suter","year":"2009","journal-title":"Vaccine"},{"key":"ref39","first-page":"3721","article-title":"Synergistic effect of bacillus calmette guerin and a tuberculosis subunit vaccine in cationic liposomes: increased immunogenicity and protection. J. Immunol","volume":"178","author":"J Dietrich","year":"2007"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e39909","DOI":"10.1371\/journal.pone.0039909","article-title":"The HyVac4 subunit vaccine efficiently boosts BCG-primed anti-mycobacterial protective immunity","volume":"7","author":"R Billeskov","year":"2012","journal-title":"PLoS One"},{"key":"ref41","first-page":"3973","article-title":"Induction of CD8 T cells against a novel epitope in TB10.4: correlation with mycobacterial virulence and the presence of a functional region of difference-1. J. Immunol","volume":"179","author":"R Billeskov","year":"2007"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/cyto.a.21015","article-title":"SPICE: Exploration and analysis of post-cytometric complex multivariate datasets","volume":"79","author":"M Roederer","year":"2011","journal-title":"Cytometry A"},{"key":"ref43","first-page":"29","article-title":"Teoria statistica delle classi e calcolo delle probabilit\u00e0","volume":"8","author":"CE Bonferroni","year":"1936","journal-title":"Pubblicazioni del R Istituto Superiore di Scienze Economiche e Commerciali di Firenze"},{"key":"ref44","first-page":"5831","article-title":"Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infect. Immun","volume":"71","author":"SV Capuano","year":"2003"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.vaccine.2010.12.135","article-title":"Ag85B-ESAT-6 adjuvanted with IC31(R) promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection","volume":"29","author":"JT van Dissel","year":"2011","journal-title":"Vaccine"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"e5139","DOI":"10.1371\/journal.pone.0005139","article-title":"CD4 and CD8 T cell responses to the M. tuberculosis Ag85B-TB10.4 promoted by adjuvanted subunit, adenovector or heterologous prime boost vaccination","volume":"4","author":"T Elvang","year":"2009","journal-title":"PLoS One"},{"key":"ref47","first-page":"247","article-title":"T-cell quality in memory and protection: implications for vaccine design. Nat. Rev. Immunol","volume":"8","author":"RA Seder","year":"2008"},{"key":"ref48","first-page":"1555","article-title":"Antigen persistence is required throughout the expansion phase of a CD4(+) T cell response. J. Exp. Med","volume":"201","author":"R Obst","year":"2005"},{"key":"ref49","first-page":"6694","article-title":"Shortening the infectious period does not alter expansion of CD8 T cells but diminishes their capacity to differentiate into memory cells. J. Immunol","volume":"173","author":"MA Williams","year":"2004"},{"key":"ref50","first-page":"153","article-title":"Comparison of the depot effect and immunogenicity of liposomes based on dimethyldioctadecylammonium (DDA), 3beta-[N-(N\u2019,N\u2019-Dimethylaminoethane)carbomyl] cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium propane (DOTAP): prolonged liposome retention mediates stronger Th1 responses. Mol. Pharm","volume":"8","author":"M Henriksen-Lacey","year":"2011"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tube.2012.02.008","article-title":"A mouse model of tuberculosis reinfection","volume":"92","author":"M Henao-Tamayo","year":"2012","journal-title":"Tuberculosis (Edinb)"},{"key":"ref52","first-page":"340","article-title":"Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model. Arthritis. Rheum","volume":"62","author":"PL Lin","year":"2010"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1016\/j.vaccine.2004.11.051","article-title":"Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6","volume":"23","author":"JA Langermans","year":"2005","journal-title":"Vaccine"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1016\/j.vaccine.2009.05.050","article-title":"Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates","volume":"27","author":"MH Larsen","year":"2009","journal-title":"Vaccine"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1073\/pnas.0712077106","article-title":"Defined tuberculosis vaccine, Mtb72F\/AS02A, evidence of protection in cynomolgus monkeys. Proc. Natl. Acad. Sci","volume":"106","author":"SG Reed","year":"2009","journal-title":"U S A"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1016\/j.vaccine.2009.01.064","article-title":"Novel prophylactic and therapeutic vaccine against tuberculosis","volume":"27","author":"M Okada","year":"2009","journal-title":"Vaccine"},{"key":"ref57","first-page":"1179","article-title":"Lessons from experimental Mycobacterium tuberculosis infections. Microbes Infect","volume":"8","author":"JL Flynn","year":"2006"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0072185","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T03:50:11Z","timestamp":1646365811000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0072185"}},"subtitle":[],"editor":[{"given":"Thomas Jens","family":"Scriba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,8,19]]},"references-count":57,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0072185","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,19]]}}}